Goldman Sachs Group Inc. 8-K Filing Report: Key Stock & Securities Insights

Based on the provided section of the financial report for Goldman Sachs Group Inc., here's a summary of the key information:

Entity Information:

Name: Goldman Sachs Group Inc.
CIK: 0000886982
Address: 200 West Street, New York, NY 10282
Phone: (212) 902-1000
SEC File Number: 001-14965

Filing Details:

Filing Type: 8-K
Filing Date: January 14, 2025

Stock Information:

Common Stock: Par value of $0.01 per share.
Preferred Stocks:
- Series A: Floating Rate Non-Cumulative Preferred Stock (represented by depositary shares).
- Series C: Floating Rate Non-Cumulative Preferred Stock (represented by depositary shares).
- Series D: Floating Rate Non-Cumulative Preferred Stock (represented by depositary shares).
Enhanced Capital Securities:
- Series II: 5.793% Fixed-to-Floating Rate Normal Automatic Preferred Enhanced Capital Securities.
- Series III: Floating Rate Normal Automatic Preferred Enhanced Capital Securities.
Medium-Term Notes:
- Series F: Callable Fixed and Floating Rate Notes due March 2031.
- Series F: Callable Fixed and Floating Rate Notes due May 2031.

Securities Listing:

All preferred shares and notes are listed on the NYSE under their respective symbols:
- Common Stock: GS
- Series A: GS PrA
- Series C: GS PrC
- Series D: GS PrD
- Series II Enhanced Capital Securities: GS/43PE
- Series III Enhanced Capital Securities: GS/43PF
- Medium-Term Notes due March 2031: GS/31B
- Medium-Term Notes due May 2031: GS/31X

Key Dates:

The report covers the period starting and ending on January 14, 2025.

Insights:

Goldman Sachs is maintaining a diverse mix of equity and debt instruments, including common stock, various series of preferred stock, and medium-term notes.
The presence of fixed-to-floating rate instruments indicates a strategy to manage interest rate risk.
The detailed listing of securities underlines the firm’s structured approach to capital raising and investor engagement.

This information is crucial for investors, analysts, and stakeholders in evaluating Goldman Sachs' financial health, capital structure, and market position.